Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival

被引:189
作者
Kim, KT
Baird, K
Ahn, JY
Meltzer, P
Lilly, M
Levis, M
Small, D
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[3] NHGRI, NIH, Canc Genet Branch, Bethesda, MD 20892 USA
[4] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA
关键词
D O I
10.1182/blood-2004-05-2006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Constitutively activating internal tandem duplication (ITD) mutations of the receptor tyrosine kinase FLT3 (Fms-like tyrosine kinase 3) play an important role in leukemogenesis, and their presence is associated with poor prognosis in acute myeloid leukemia (AML). To better understand FLT3 signaling in leukemogenesis, we have examined the changes in gene expression induced by FLT3/ITD or constitutively activated wild-type FLT3 expression. Microarrays were used with RNA harvested before and after inhibition of FLT3 signaling. Pim-1 was found to be one of the most significantly down-regulated genes upon FLT3 inhibition. Pim-1 is a proto-oncogene and is known to be up-regulated by signal transducer and activator of transcription 5 (STAT5), which itself is a downstream target of FLT3 signaling. Quantitative polymerase chain reaction (QPCR) confirmed the microarray results and demonstrated approximately 10-fold decreases in Pim-1 expression in response to FLT3 inhibition. Pim-1 protein also decreased rapidly in parallel with decreasing autophosphorylation activity of FLT3. Enforced expression of either the 44-kDa or 33-kDa Pim-1 isotypes resulted in increased resistance to FLT3 inhibition-mediated cytotoxicity and apoptosis. In contrast, expression of a dominant-negative Pim-1 construct accelerated cytotoxicity in response to FLT3 inhibition and inhibited colony growth of FLT3/ITD-transformed BaF3 cells. These findings demonstrate that constitutively activated FLT3 signaling up-regulates Pim-1 expression in leukemia cells. This up-regulation contributes to the proliferative and antiapoptotic pathways induced by FLT3 signaling. (C) 2005 by The American Society of Hematology.
引用
收藏
页码:1759 / 1767
页数:9
相关论文
共 54 条
  • [1] THE HUMAN PROTOONCOGENE PRODUCT P33PIM IS EXPRESSED DURING FETAL HEMATOPOIESIS AND IN DIVERSE LEUKEMIAS
    AMSON, R
    SIGAUX, F
    PRZEDBORSKI, S
    FLANDRIN, G
    GIVOL, D
    TELERMAN, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8857 - 8861
  • [2] Pim-1 associates with protein complexes necessary for mitosis
    Bhattacharya, N
    Wang, ZP
    Davitt, C
    McKenzie, IFC
    Xing, PX
    Magnuson, NS
    [J]. CHROMOSOMA, 2002, 111 (02) : 80 - 95
  • [3] BIRG F, 1992, BLOOD, V80, P2584
  • [4] VERY HIGH-FREQUENCY OF LYMPHOMA INDUCTION BY A CHEMICAL CARCINOGEN IN PIM-1 TRANSGENIC MICE
    BREUER, M
    SLEBOS, R
    VERBEEK, S
    VANLOHUIZEN, M
    WIENTJENS, E
    BERNS, A
    [J]. NATURE, 1989, 340 (6228) : 61 - 63
  • [5] BREUER M, 1991, CANCER RES, V51, P958
  • [6] Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias
    Carow, CE
    Levenstein, M
    Kaufmann, SH
    Chen, J
    Amin, S
    Rockwell, P
    Witte, L
    Borowitz, MJ
    Civin, CI
    Small, D
    [J]. BLOOD, 1996, 87 (03) : 1089 - 1096
  • [7] CUYPERS HT, 1984, CELL, V37, P141
  • [8] DASILVA N, 1994, LEUKEMIA, V8, P885
  • [9] DeRisi J, 1996, NAT GENET, V14, P457
  • [10] Delineation of prognostic biomarkers in prostate cancer
    Dhanasekaran, SM
    Barrette, TR
    Ghosh, D
    Shah, R
    Varambally, S
    Kurachi, K
    Pienta, KJ
    Rubin, MA
    Chinnaiyan, AM
    [J]. NATURE, 2001, 412 (6849) : 822 - 826